medigraphic.com
SPANISH

Revista Mexicana de Urología

Organo Oficial de la Sociedad Mexicana de Urología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2007, Number 4

<< Back Next >>

Rev Mex Urol 2007; 67 (4)

Carcinoma urotelial del tracto urinario superior. Experiencia en el Hospital General “Dr. Manuel Gea González”

Andrade PJD, Cantellano OM, Fernández CAJ, Morales MJG, Pacheco GC, Calderón FF
Full text How to cite this article

Language: Spanish
References: 6
Page: 206-211
PDF size: 277.98 Kb.


Key words:

renal pelvis, ureter, perirenal hematoma, hematuria, upper urinary tract, urotelial carcinoma, urinary cytology, Wunderlich syndrome.

ABSTRACT

Background: 4% of urological neoplasms arise in the upper urinary tract (UUT). Mexican incidence reported 23 new cases and 3 deaths during 2000 representing 10% of all renal tumors. 5% are bilateral and distal ureter is the most frequently affected. Hematuria is present in 75%.
Material and methods: Is a cross sectional study. We reviewed 16 cases of urothelial carcinoma of the upper urinary tract during a period of 17 years. We assessed localization, TNM stage, tumor grade, treatment, correlation with bladder cancer, evolution and relapse.
Results: 16 patients with an average age of 61 years with a mean follow up of 45 months. 4 cases coexisted with bladder cancer. Haematuria was present in all cases, 5 with positive urinary cytology. All cases were treated with nephroureterectomy with vesical cuff. pT stage included T1 (7), T2 (5) and T3 (4); 4 and 10 had low and high grade tumors, respectively. 37% were localized in renal pelvis, 25% in ureter and 37% in both. Those associated with bladder tumor, 2 had superficial and 2 invasive tumors. Specific death mortality was 25% (4).
Conclusions: UUT tumors are rare, 25% associated to bladder cancer. Low frequency of local recurrence, related to clinical stage, the bladder recurrences presents in 50%. The treatment is indicated by localization and clinical stage.


REFERENCES

  1. Clark PE, Streem SB, Geisinger MA. 13-year experiencie with percutaneous management of upper tract transitional cell carcinoma. J Urol. 1999;161(3):772-6.

  2. Chen GL, El-Gabry EA, Bagley DH. Surveillance of upper urinary tract transitional cell carcinoma: the role of ureteroscopy, retrograde pyelography, cytology and urinalysis. J Urol. 2000;164(6):1901-4.

  3. Czito B, Zietman A. Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter. J Urol. 2004;172(4):1271-5.

  4. Palou J, Rodriguez-Rubio F, Huguet J, Segarra J et al. Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor. J Urol. 2005;174 (3):859-61.

  5. Schouffoer AA, Siegert CE, Arend SM, Thompson J, Van Oostaijen JA. Embolization of a ruptured aneurism in classic poliarteritis nodosa presenting as perirenal hematoma. Arch Intern Med. 1998;158: 1466-8.

  6. Park S, Hong B, Kim CS, Ahn H. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J Urol. 2004;171(2):62-625.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Urol. 2007;67